If you need more than just Biomarker w/No Alteration lab test - add more tests one by one.

Please select an item from the autocomplete list

Max stores per result: Verbose: See search details (0.0 seconds, 1 steps, 1 combinations )
Switch to LabCorp lab tests (similar)

Laboratory tests search details

Biomarker w/No Alteration (component) (remove)

Stores: Jason Health

Components: Biomarker w/No Alteration

Biomarker w/No Alteration test cost is between $4273.00 and $4273.00

None

$4273.00
Order

Jason Health

LeukoVantage®, Myeloproliferative Neoplasms (MPN)

Covered tests: LeukoVantage®, Myeloproliferative Neoplasms (MPN) (partial) (Quest)
Extra tests (click to add to search): LeukoVantage®, Myeloproliferative Neoplasms (MPN) (partial) (Quest)

Covered components: Biomarker w/No Alteration

Extra components (click to add to search): Overall Result, Overall Summary, Gene 1, Mutation 1 P, Mutation 1 C, Mutation Frequency 1, Clinical Significance 1, Available Therapies 1, Resistance to Therapies 1, and 395 more

Clinical Trials 1 , Mutation Effect Variant 1 , Clin Relevance Variant 1 , Prognostic Sig Variant 1 , Diagnostic Sig Variant 1 , Related Therapies 1 , Unrelated Therapies 1 , Resistance 1 , Eff on Drug Sensit 1 , Eff on Drug Resist 1 , Gene 1 Trial ID 1 , Gene 1 Title 1 , Gene 1 Targets 1 , Gene 1 Trial ID 2 , Gene 1 Title 2 , Gene 1 Targets 2 , Gene 1 Trial ID 3 , Gene 1 Title 3 , Gene 1 Targets 3 , Gene 1 Trial ID 4 , Gene 1 Title 4 , Gene 1 Targets 4 , Gene 1 Trial ID 5 , Gene 1 Title 5 , Gene 1 Targets 5 , Gene 1 Trial ID 6 , Gene 1 Title 6 , Gene 1 Targets 6 , Gene 1 Trial ID 7 , Gene 1 Title 7 , Gene 1 Targets 7 , Gene 1 Trial ID 8 , Gene 1 Title 8 , Gene 1 Targets 8 , Gene 1 Trial ID 9 , Gene 1 Title 9 , Gene 1 Targets 9 , Gene 1 Trial ID 10 , Gene 1 Title 10 , Gene 1 Targets 10 , Footnote for Variant , Gene 2 , Mutation 2 P , Mutation 2 C , Mutation Frequency 2 , Clinical Significance 2 , Available Therapies 2 , Resistance to Therapies 2 , Clinical Trials 2 , Mutation Effect Variant 2 , Clin Relevance Variant 2 , Prognostic Sig Variant 2 , Diagnostic Sig Variant 2 , Related Therapies 2 , Unrelated Therapies 2 , Resistance 2 , Effect on Drug Sensit 2 , Effect on Drug Resist 2 , Gene 2 Trial ID 1 , Gene 2 Title 1 , Gene 2 Targets 1 , Gene 2 Trial ID 2 , Gene 2 Title 2 , Gene 2 Targets 2 , Gene 2 Trial ID 3 , Gene 2 Title 3 , Gene 2 Targets 3 , Gene 2 Trial ID 4 , Gene 2 Title 4 , Gene 2 Targets 4 , Gene 2 Trial ID 5 , Gene 2 Title 5 , Gene 2 Targets 5 , Gene 2 Trial ID 6 , Gene 2 Title 6 , Gene 2 Targets 6 , Gene 2 Trial ID 7 , Gene 2 Title 7 , Gene 2 Targets 7 , Gene 2 Trial ID 8 , Gene 2 Title 8 , Gene 2 Targets 8 , Gene 2 Trial ID 9 , Gene 2 Title 9 , Gene 2 Targets 9 , Gene 2 Trial ID 10 , Gene 2 Title 10 , Gene 2 Targets 10 , Gene 3 , Mutation 3 P , Mutation 3 C , Mutation Frequency 3 , Clinical Significance 3 , Available Therapies 3 , Resistance to Therpies 3 , Clinical Trials 3 , Mutation Effect Variant 3 , Clin Relevance Variant 3 , Prognostic Sig Variant 3 , Diagnostic Sig Variant 3 , Related Therapies 3 , Unrelated Therapies 3 , Resistance 3 , Effect on Drug Sensit 3 , Effect on Drug Resist 3 , Gene 3 Trial ID 1 , Gene 3 Title 1 , Gene 3 Targets 1 , Gene 3 Trial ID 2 , Gene 3 Title 2 , Gene 3 Targets 2 , Gene 3 Trial ID 3 , Gene 3 Title 3 , Gene 3 Targets 3 , Gene 3 Trial ID 4 , Gene 3 Title 4 , Gene 3 Targets 4 , Gene 3 Trial ID 5 , Gene 3 Title 5 , Gene 3 Targets 5 , Gene 3 Trial ID 6 , Gene 3 Title 6 , Gene 3 Targets 6 , Gene 3 Trial ID 7 , Gene 3 Title 7 , Gene 3 Targets 7 , Gene 3 Trial ID 8 , Gene 3 Title 8 , Gene 3 Targets 8 , Gene 3 Trial ID 9 , Gene 3 Title 9 , Gene 3 Targets 9 , Gene 3 Trial ID 10 , Gene 3 Title 10 , Gene 3 Targets 10 , Gene 4 , Mutation 4 P , Mutation 4 C , Mutation Frequency 4 , Clinical Significance 4 , Available Therapies 4 , Resistance to Therapies 4 , Clinical Trials 4 , Mutation Effect Variant 4 , Clin Relevance Variant 4 , Prognostic Sig Variant 4 , Diagnostic Sig Variant 4 , Related Therapies 4 , Unrelated Therapies 4 , Resistance 4 , Effect on Drug Sensit 4 , Effect on Drug Resist 4 , Gene 4 Trial ID 1 , Gene 4 Title 1 , Gene 4 Targets 1 , Gene 4 Trial ID 2 , Gene 4 Title 2 , Gene 4 Targets 2 , Gene 4 Trial ID 3 , Gene 4 Title 3 , Gene 4 Targets 3 , Gene 4 Trial ID 4 , Gene 4 Title 4 , Gene 4 Targets 4 , Gene 4 Trial ID 5 , Gene 4 Title 5 , Gene 4 Targets 5 , Gene 4 Trial ID 6 , Gene 4 Title 6 , Gene 4 Targets 6 , Gene 4 Trial ID 7 , Gene 4 Title 7 , Gene 4 Targets 7 , Gene 4 Trial ID 8 , Gene 4 Title 8 , Gene 4 Targets 8 , Gene 4 Trial ID 9 , Gene 4 Title 9 , Gene 4 Targets 9 , Gene 4 Trial ID 10 , Gene 4 Title 10 , Gene 4 Targets 10 , Gene 5 , Mutation 5 P , Mutation 5 C , Mutation Frequency 5 , Clinical Significance 5 , Available Therapies 5 , Resistance to Therapies 5 , Clinical Trials 5 , Mutation Effect Variant 5 , Clin Relevance Variant 5 , Prognostic Sig Variant 5 , Diagnostic Sig Variant 5 , Related Therapies 5 , Unrelated Therapies 5 , Resistance 5 , Effect on Drug Sensit 5 , Effect on Drug Resist 5 , Gene 5 Trial ID 1 , Gene 5 Title 1 , Gene 5 Targets 1 , Gene 5 Trial ID 2 , Gene 5 Title 2 , Gene 5 Targets 2 , Gene 5 Trial ID 3 , Gene 5 Title 3 , Gene 5 Targets 3 , Gene 5 Trial ID 4 , Gene 5 Title 4 , Gene 5 Targets 4 , Gene 5 Trial ID 5 , Gene 5 Title 5 , Gene 5 Targets 5 , Gene 5 Trial ID 6 , Gene 5 Title 6 , Gene 5 Targets 6 , Gene 5 Trial ID 7 , Gene 5 Title 7 , Gene 5 Targets 7 , Gene 5 Trial ID 8 , Gene 5 Title 8 , Gene 5 Targets 8 , Gene 5 Trial ID 9 , Gene 5 Title 9 , Gene 5 Targets 9 , Gene 5 Trial ID 10 , Gene 5 Title 10 , Gene 5 Targets 10 , Gene 6 , Mutation 6 P , Mutation 6 C , Mutation Frequency 6 , Clinical Significance 6 , Available Therapies 6 , Resistance to Therapies 6 , Clinical Trials 6 , Mutation Effect Variant 6 , Clin Relevance Variant 6 , Prognostic Sig Variant 6 , Diagnostic Sig Variant 6 , Related Therapies 6 , Unrelated Therapies 6 , Resistance 6 , Effect on Drug Sensit 6 , Effect on Drug Resist 6 , Gene 6 Trial ID 1 , Gene 6 Title 1 , Gene 6 Targets 1 , Gene 6 Trial ID 2 , Gene 6 Title 2 , Gene 6 Targets 2 , Gene 6 Trial ID 3 , Gene 6 Title 3 , Gene 6 Targets 3 , Gene 6 Trial ID 4 , Gene 6 Title 4 , Gene 6 Targets 4 , Gene 6 Trial ID 5 , Gene 6 Title 5 , Gene 6 Targets 5 , Gene 6 Trial ID 6 , Gene 6 Title 6 , Gene 6 Targets 6 , Gene 6 Trial ID 7 , Gene 6 Title 7 , Gene 6 Targets 7 , Gene 6 Trial ID 8 , Gene 6 Title 8 , Gene 6 Targets 8 , Gene 6 Trial ID 9 , Gene 6 Title 9 , Gene 6 Targets 9 , Gene 6 Trial ID 10 , Gene 6 Title 10 , Gene 6 Targets 10 , Gene 7 , Mutation 7 P , Mutation 7 C , Mutation Frequency 7 , Clinical Significance 7 , Available Therapies 7 , Resistance to Therapies 7 , Clinical Trials 7 , Mutation Effect Variant 7 , Clin Relevance Variant 7 , Prognostic Sig Variant 7 , Diagnostic Sig Variant 7 , Related Therapies 7 , Unrelated Therapies 7 , Resistance 7 , Effect on Drug Sensit 7 , Effect on Drug Resist 7 , Gene 7 Trial ID 1 , Gene 7 Title 1 , Gene 7 Targets 1 , Gene 7 Trial ID 2 , Gene 7 Title 2 , Gene 7 Targets 2 , Gene 7 Trial ID 3 , Gene 7 Title 3 , Gene 7 Targets 3 , Gene 7 Trial ID 4 , Gene 7 Title 4 , Gene 7 Targets 4 , Gene 7 Trial ID 5 , Gene 7 Title 5 , Gene 7 Targets 5 , Gene 7 Trial ID 6 , Gene 7 Title 6 , Gene 7 Targets 6 , Gene 7 Trial ID 7 , Gene 7 Title 7 , Gene 7 Targets 7 , Gene 7 Trial ID 8 , Gene 7 Title 8 , Gene 7 Targets 8 , Gene 7 Trial ID 9 , Gene 7 Title 9 , Gene 7 Targets 9 , Gene 7 Trial ID 10 , Gene 7 Title 10 , Gene 7 Targets 10 , Gene 8 , Mutation 8 P , Mutation 8 C , Mutation Frequency 8 , Clinical Significance 8 , Available Therapies 8 , Resistance to Therapies 8 , Clinical Trials 8 , Mutation Effect Variant 8 , Clin Relevance Variant 8 , Prognostic Sig Variant 8 , Diagnostic Sig Variant 8 , Related Therapies 8 , Unrelated Therapies 8 , Resistance 8 , Effect on Drug Sensit 8 , Effect on Drug Resist 8 , Gene 8 Trial ID 1 , Gene 8 Title 1 , Gene 8 Targets 1 , Gene 8 Trial ID 2 , Gene 8 Title 2 , Gene 8 Targets 2 , Gene 8 Trial ID 3 , Gene 8 Title 3 , Gene 8 Targets 3 , Gene 8 Trial ID 4 , Gene 8 Title 4 , Gene 8 Targets 4 , Gene 8 Trial ID 5 , Gene 8 Title 5 , Gene 8 Targets 5 , Gene 8 Trial ID 6 , Gene 8 Title 6 , Gene 8 Targets 6 , Gene 8 Trial ID 7 , Gene 8 Title 7 , Gene 8 Targets 7 , Gene 8 Trial ID 8 , Gene 8 Title 8 , Gene 8 Targets 8 , Gene 8 Trial ID 9 , Gene 8 Title 9 , Gene 8 Targets 9 , Gene 8 Trial ID 10 , Gene 8 Title 10 , Gene 8 Targets 10 , Variants of Unknown Sig , Region w/Poor Seq Quality , Biomarker1 1 , Biomarker2 1 , Resistant Therapies 1 , Synergistic Therapies 1 , Diagnostic Evidence 1 , Prognostic Evidence 1 , Interaction Summary 1 , Biomarker1 2 , Biomarker2 2 , Resistant Therapies 2 , Synergistic Therapies 2 , Diagnostic Evidence 2 , Prognostic Evidence 2 , Interaction Summary 2 , Biomarker1 3 , Biomarker2 3 , Resistant Therapies 3 , Synergistic Therapies 3 , Diagnostic Evidence 3 , Prognostic Evidence 3 , Interaction Summary 3 , Footnote , Level of Evidence Descrip , Additional Information

Blacklisted States: NY, NJ, RI

$4255.00

Jason Health

Requisition Charge (per order charge)

$18.00
$4273.00
Order from Jason Health
LeukoVantage®, Myeloproliferative Neoplasms (MPN) $4255.00

Go to Checkout and complete the checkout process there. Your total price should be $4273.00 ($4255.00 panels price + $18.00 requisition charge)

Understanding of Lab Tests Results

Please visit the site associated with The American Association for Clinical Chemistry (AACC) for better understanding of tests. There you will find the most detailed and full information regarding lab tests. In "common questions" tab you will find answers on the most common questions.

In addition, you can use a special form to ask the question. It is useful, if there is no answer on your question on the web site. A laboratory scientist will answer your question. It is a part of voluntary service provided by the American Society for Clinical Laboratory Science.